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Abstract
Background: The EpiCom-study investigates a possible East-West-gradient in Europe in the
incidence of IBD and the association with environmental factors. A secured web-based database
is used to facilitate and centralize data registration.
Aim: To construct and validate a web-based inception cohort database available in both English
and Russian language.
Method: The EpiCom database has been constructed in collaboration with all 34 participating by guest on Ja
http://ecco-jcc.oxfordjournals.org/
ded from
 centers. The database was translated into Russian using forward translation, patient
questionnaires were translated by simplified forward-backward translation. Data insertion
implies fulfillment of international diagnostic criteria, disease activity, medical therapy, quality
of life, work productivity and activity impairment, outcome of pregnancy, surgery, cancer and
death. Data is secured by the WinLog3 System, developed in cooperation with the Danish Data
Protection Agency. Validation of the database has been performed in two consecutive rounds,
each followed by corrections in accordance with comments.
Results: The EpiCom database fulfills the requirements of the participating countries’ local data
security agencies by being stored at a single location. The database was found overall to be
“good” or “very good” by 81% of the participants after the second validation round and the
general applicability of the database was evaluated as “good” or “very good” by 77%. In the
inclusion period January 1st –December 31st 2010 1336 IBD patients have been included in the
database.
Conclusion: A user-friendly, tailor-made and secure web-based inception cohort database has
been successfully constructed, facilitating remote data input. The incidence of IBD in 23
European countries can be found at www.epicom-ecco.eu.
© 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.nuary 16, 20171. Introduction
The Epidemiology Committee (EpiCom) web-based study (EpiCom,
www.epicom-ecco.eu) was initiated during the period 2006–2010,
when Pia Munkholm was chairing the EpiCom in ECCO. Johan Burisch
was elected as the first EpiCom PhD-student at the University of
Copenhagen, being the lead figure in the database construction and
the subsequent inception cohort studies.
The study was initiated to better define the burden of illness of
inflammatory bowel disease (IBD), to explore the mechanism of
association of IBD with environmental factors, as well as to identify
new risk factors in the environment across the borders. The EpiCom-
study will create a new prospective, uniformly diagnosed, popula-
tion-based inception cohort of patients diagnosed with IBD in a one-
year period, 01.01.2010–31.12.2010 within well-defined geograph-
ical areas in both Western and Eastern Europe. The follow-up period
(FU) will last from inclusion until 31.12.2011.
For the first time in Europe, scientists will be able to describe
differences among geographical regions across Europe and to
demonstrate the impact of lifestyle on the incidence of IBD. 34
centers from 23 countries representing adult and pediatric inception
cohorts from 15 Western European countries, 8 Eastern Europeancountries and 1 Asian country, Wuhan city in China, are participating
(Table 1).
The overall aim of the EpiCom-study is to investigate whether
there is an East–West-gradient in the incidence of IBD in European
countries and, in addition, whether the difference in IBD incidence is
associated with dissimilarities in environmental exposure. One year
after the project start, a follow-up stage will be launched to analyze
whether there are differences throughout Europe in respect of:
- Vitamin D levels
- Quality of life and quality of care gradient
- Prognosis in terms of disease progression, surgery, mortality,
cancer and pregnancy out-come
- Work Productivity and Activity impairment
- The prevalence of extra-intestinal manifestation
- The effect of different economic considerations on choice of
treatment strategies
- Geographical effect on disease severity
- The impact of migration
- The incidence of primary sclerosing cholangitis
- The incidence of chronic viral hepatitis B and C and of HIV
infection in IBD
Table 1 List of participants.
Western Europe [14 countries]
Cyprus John Kaimakliotis
Michael Tryphonos
Denmark Soeren Avnstroem
Lisbet Ambrosius Christensen
Jens F. Dahlerup
Vibeke Andersen
Jens Kjeldsen
Johan Burisch
Pia Munkholm
Natalia Pedersen
Ebbe Langholz
Margarita Elkjaer
Anders Pærregaard
Niels Thorsgaard Pedersen
Faroe Islands Kári R. Nielsen
Finland Pekka Collin
Pia Manninen
Kaija-Leena Kolho
Matti Verkasalo
Greece Epameinondas V. Tsianos
Konstantinos H. Katsanos
Ioannis Vagias
Greenland Karin Ladefoged
Iceland Einar Bjoernsson
Sjöfn Kristjansdottir
Ireland Colm O'Morain
Mary Shuhaibar
Israel Selwyn Odes
Ohad Etzion
Italy Sergio Gullini
Angelo Zelante
Loredana Simone
Reinhold Stockbrugger
Matteo Martinato
Renata D'Incà
Giovanni Fornaciari
Marina Beltrami
Daniela Valpiani
Monica Milla
Portugal Fernando Magro
Luisa Manuela Barros
Spain Alberto Fernandez Villaverde
David Martinez Ares
Vicent Hernandez Ramirez
Santos Pereira
Guillermo Bastida
Joan Clofent
Sweden Sven Almer
Jonas Halfvarson
Curt Tysk
Erik Hertervig
United Kingdom Ailsa Hart
Warren Hyer
Naila Arebi
Shaji Sebastian
Eastern Europe [8 countries]
Croatia Boris Vucelic
Silvija Cukovic-Cavka
Czech Republic Olga Shonová
Zdenka Krocáková
Martin Bortlik
Milan Lukas
Dana Duricova
Miroslava Adamcova
Hungary Peter Lakatos
Lithuania Limas Kupcinskas
Gediminas Kiudelis
Ruta Kucinskien
Moldova Ion Mihu
Olga Tighineanu
Viorica Pleşca
Svetlana Turcan
Romania Adrian Goldis
Russia Elena Belousova
Inna Nikulina
Asia [1 country]
China Siew Ng
Michael Kamm
Joseph Sung
Bing Xia
Pinjin Hu
Table 1 (continued)
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 In order to facilitate data acquisition, to ensure data quality, as
well as to enable centralization of data storage, a secure web-based
database was constructed with the purpose of providing a basis for
completing the aims of the EpiCom-study. The web-based database
was optimized with respect to accuracy, functionality, cost-
effectiveness and visual presentation. The Copenhagen diagnostic
criteria were used,1–4 to increase the internal validity. In addition,
the database should give the users online reporting of current
inclusion and incidence rates for each cohort involved.
The aim of this paper is to describe the construction and
validation of the web-based inception cohort database, available in
both English and Russian language. Future papers will address the
inclusion process as well as the incidences of IBD in Europe.2. Methods
2.1. Database Construction in English
The development of the web-based EpiCom database application
was carried out by HD-support LLC, Denmark, over a period of
approximately two years. The construction of the database required
a series of interviews by HD-support with the project steering group
regarding the content and structure of the database, as well as
agreeing on an initial feature list for the prototype construction.
These issues were then discussed with all EpiCom-members and
comments and additional suggestions were implemented. Since 2006
EpiCom members had been meeting regularly at international
congresses: European Crohn's and Colitis Organization congress,
Digestive Disease Week, United European Gastroenterology Week
and Nordic Gastroenterology Congress.
345Construction and validation of a web2based epidemiological databased for IBDThe database was programmed at the same time as being
continually released to the steering group for testing, which reported
defects and requested new features or amendments to those already
existing. In addition, there was an ongoing internal testing by the
developers. After having secured a certain number of features, a
validation release was provided for all participants, allowing them to
test the database, offer comments on the design, and report defects.
The validation process was repeated twice (December 2008–June
2009), followed by corrections of reported defects. After a satisfactory
validation of the project, the feature list was frozen, preventing
further changes/additions to the feature list.
A website, www.epicom-ecco.eu, was created for this project,
permitting access to the database and containing contact informa-
tion as well as the EpiCom-project protocol, available to anyone in
the world for the purpose of transparency. In addition, an inclusion
chart was created on the front page of the website showing both the
current number of patients included in the database as well as theChina, Wuhan        1,65 
Croatia, Zagreb       3,48 
Cyprus, Nicosia       7,08 
Czech Republic, Praha (incl. Pediatric)    7,39 
Czech Republic, South Bohemian Region    8,84 
Denmark, Amager       9,91 
Denmark, Funen (incl. Pediatric)     28,40 
Denmark, Herlev (incl. Pediatric)     18,69 
Denmark, Herning       14,52 
Denmark, Viborg       35,89 
Denmark, Aarhus Kommune      18,27 
Estonia, Southern Estonia (incl. Pediatric)    9,60 
Faroe Island, Faroe Islands      77,52 
Finland, Helsinki and Uusimaa     0,00 
Finland, Pirkanmaa       8,94 
Greece, Ioannina       8,15 
Greenland, Nuuk       15,94 
Hungary, Veszprem province      14,45 
Iceland, Iceland       21,15 
Ireland, Adelaide and Meath      7,27 
Israel, Beer Sheva and Northern Negev    7,89 
Italy, Northern Italy       7,01 
Lithuania, Kaunas city and district     6,64 
Moldova, (Pediatric Center)      0,38 
Moldova, Chisinau       2,90 
Portugal, Vale de Sousa      7,85 
Romania, Timis       3,28 
Russia, Moscow       3,58 
Spain, Valencia       9,42 
Spain, Vigo (incl. Pediatric)      14,03 
Sweden, Linkoping       28,64 
Sweden, Middle Scania      6,17 
Sweden, Orebro       18,71 
Switzerland, Canton o Vaud      0,45 
United Kingdom, Brent and Harrow     3,96 
United Kingdom, Hull and East Yorkshire    9,83 
Center              Current incidence  
Incidence calculator - Total [n = 1336]
”Is there an East-West gradient in Europe in IBD
  1. 1. 2010 - 31. 12. 2011 - www.epicom-ecco.eu
Get the protocol How to participate    Log in to database
Figure 1 The front page of www.epicom-ecco.eu, displaying cur
calculated incidence, as of December 31st 2010.current incidence for each participating center. Thereby the
inclusion of patients can be followed live, Fig. 1.2.2. Database Cost
The EpiCom database was constructed by HD-support for a price of €
75.000 funded by a private organization and the pharmaceutical
industry. Each participating center has to pay a yearly fee of € 2.200
for 2010 and €1.500 for 2011 in order to use the database. This fee
covers the expenses for user administration, user support, contin-
uous correcting of minor logistical errors in the database as well as
the hosting of the EpiCom-server (Backup, hardware maintenance,
and software maintenance) by HD-support. In the future, after the
end of the EpiCom-study in 2012, the database will be available for
everyone interested in gaining access.    59  3527350
    8  227489
    25  350000
    19  255000
    45  504819
    16  160064
    128  447000
    49  260000
    42  286865
    38  105000
    55  298538
    28  289278
    35  44778
    0
    43  476631
    14  170239
    9  56000
    43  295000
    64  300000
    22  300000
    45  565300
    155  2192167
    31  463000
    14  3567500
    8  273000
    26  328389
    22  664433
    19  525000
    15  157860
    82  579632
    49  169671
    19  305000
    28  148382
    3  647382
    20  500000
    58  585000
          Actual number IBD   Background population
 caused by environmental factors?”
rent numbers of IBD patients included per center and current
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DIAGNOSIS     Diagnostic criteria        entry
Clinical data             Patient activity      At each visit
DeathCancerBloodBiologicsPregnancyOperation
Rare ”EVENTS”
Figure 2 Schematic outline of the schemes used in the database.
346 J. Burisch et al.
 by guest on January 16, 2017
http://ecco-jcc.oxfordjournals.org/
D
ow
nloaded from
 2.3. Database Design and Content
The web-based EpiCom Database application has been designed on
the basis of the Danish Crohn Colitis Database (DCCD), www.dccd-
ibd.dk, aiming strictly to be an epidemiological database focusing on
academic and epidemiological content in contrast to clinical
applicability. The database was used for online registration of the
various forms used in the EpiCom-project. In order to be able to
follow and document the clinical course of patients included in the
project, the database was built up around 9 clinical schemes
covering all aspects of the course of the disease. The clinical
schemes were divided into entry schemes, schemes used for each
patient visit, and schemes used for rare events, Fig. 2.
The entry schemes include a diagnostic criteria scheme, containing
data regarding diagnosis, disease extent and behavior, performed
examinations and patient demographic details. The schemes used at
each patient visit include a disease activity scheme, a blood sample
scheme for registration of blood analysis including vitamin D as well as
a clinical assessment scheme regarding disease status, treatment, and
examinations performed since last visit. To measure the disease
activity, the EpiCom-database uses the internationally validated
Harvey–Bradshaw index (HB)5 for CD and Simple Clinical Colitis
Activity Index (SCCAI) 6 for UC. For pediatric patients' disease activity
the Pediatric Ulcerative Colitis Activity Index (PUCAI)7 and the
Pediatric Crohn's Disease Activity Index (PCDAI)8 are being used. The
rare event schemes include specific schemes regarding surgery, death
and cancer using ICD-10 codes as well as schemes regarding pregnancy
outcome and the use of biological treatment.
For the purpose of answering the questions of the EpiCom-
project regarding quality of care (QoC), quality of life (QoL), work
productivity and activity impairment (WPAI) as well as to investigate
the role of environmental factors in incidence of IBD, internationally
validated questionnaires and schemes were implemented in the
EpiCom-database. Regarding environmental factors in IBD, the
questionnaire proposed by the IOIBD (International Organization of
Inflammatory Bowel Disease) is used.9 To measure patients' health-
related quality of life, the short Inflammatory Bowel Disease
Questionnaire (s-IBDQ)10 is used, while the Health Survey SF-1211,12
is used for measuring general wellbeing.
To describe the quality of health care in Eastern and Western
European countries, a questionnaire with particular regard to the
physician's background, physician's education in IBD, patient's level
of information on treatment, monitoring of drug adverse events and
colorectal cancer surveillance was developed. The questionnaire
was created on the basis of the ECCO consensus about IBD patients'
needs in health quality of care.13 The Nurse EpiCom group in 10
countries was formed and a QoC questionnaire focusing on nursing
was constructed. To measure the effect of overall health and
specific symptoms on productivity at work and outside of it, the
WPAI Questionnaire14 has been implemented.
All used questionnaires will be available in English and Russian
language in the database. The SF-12, s-IBDQ and WPAI are available
in a number of validated translations and the participants will beable to use versions in their local language. The IOIBD environmental
factors scheme is only available in English and in a validated Danish
version.15
The database has built-in control and validation tests in the
schemes used, thereby making sure to avoid missing data and
inconsistencies. It is impossible to enter invalid data, particularly in
the form of patients who do not fulfill the required Copenhagen
Diagnostic Criteria for CD and UC. To ensure anonymity, patients are
only registered by date of birth and by a unique patient-ID number.
The patient-ID consists of five elements: patient inclusion number
(six digits); date of birth (six digits); gender (M/F); center number
(three digits); and country number (three digits).
To answer the questions of the EpiCom-study, 13 work packages
were created by the participant teams with elected leaders
responsible for carrying out the work packages, Table 2.2.4. Database Security
The EpiCom Database is located on a central secure server in the
professional hosting center Athena Hosting in Denmark, located in a
former regional branch of the National Bank of Denmark. The data is
stored in a secure database engine, including backup. The entered
data is secured by the WinLog3 Security System, which has been
developed in cooperation with the Danish Data Protection Agency. It
is thereby possible for all participants to share data across their
borders while those same data are stored at a single location.
Participating centers will only be able to view patient data from
their own center, as they have no access to data from other centers,
apart from the calculation of the cumulative patient inclusion at the
front page.2.5. Database Validation
A validation scheme was created for the purpose of the database
validation. The validation scheme contained questions regarding
general use of the database, time consumption, the overall
impression and satisfaction, as well as the relevance and applica-
bility of the questionnaires and schemes used in the database.
Furthermore, participants were asked about their previous experi-
ence with inception cohort studies as well as their catchment area.
Fictional patient cases were created, involving both CD and UC.
Participants were also encouraged to invent their own cases or
clinical scenarios in order to test all features of the database.
The validation underwent two rounds. All participants in the
EpiCom-project were invited to take part in the validation process.
They were provided with two IBD cases and the validation scheme
and were encouraged to comment on the content and usability of the
database. Comments, reported defects and requests for changes in/
additions to the feature list were taken into consideration and
implemented in the database. The process was then repeated with
two new IBD cases, followed by further corrections and changes.
Table 2 EpiCom work packages.
Work package Leader
WP 1: Inception group construction, environmental factors JB, NP, PM (Denmark)
WP 2: Database construction and data management BD (Denmark)
WP 3: IBD diagnostics JB, NP, PM, Peter Lakatos (Hungary)
WP 4: Quality of care JB, NP, PM — nurses Birgit Laugesen, Dorte Marker,
Hanne Scherfig (Denmark)
WP 5: Quality of life JB, NP, PM, Mary Shuhaibar (Ireland)
WP 6: Surgery JB, NP, PM
WP 7: Cancer, survival Epameinondas V. Tsianos, Kostas Katsanos (Greece),
Peter Lakatos (Hungary), Vicent Hernandez (Spain)
WP 8: Pediatrics (b15 years), pregnancy outcome JB, NP, PM, Pia Manninen (Finland),
Dana Duricova (Czech Republic)
WP 9: Health care costs Selwyn Odes (Israel), Limas Kupcinskas (Lithuania)
WP 10: Biologicals JB, NP, PM
WP 11: Primary sclerosing cholangitis Einar S. Björnsson (Iceland)
WP 12: Europe–China gradient Siew Chien Ng (China)
WP 13: Chronic viral hepatitis B and C and HIV Epameinondas V. Tsianos, Kostas Katsanos (Greece)
JB: Johan Burisch; NP: Natalia Pedersen; PM: Pia Munkholm; and BD: Birger Dinesen — Denmark.
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 2.6. Database Translation into Russian
The majority of the Eastern parts of Europe does understand the
Russian language to some extent. Therefore a Russian version of the
database was developed to ease inclusion of data as well as the
patients' understanding of the questionnaires. The EpiCom-database,
including schemes constructed by the steering group (diagnostic
criteria, clinical assessment, blood samples and rare event scheme) as
well as disease activity schemes, was translated from English into
Russian by three health care professionals together with the steering
group. While being translated, the database underwent continuous
testing as well as qualitative and quantitative evaluations by the
translators to ensure semantic equivalence.
The questionnaires to be completed by the patients themselves
(s-IBDQ, SF12, WPAI, Quality of care and environmental factors)
were translated using a simplified forward–backward translation.16
The questionnaires were translated forward by a bilingual non-
health care professional into Russian. Problematic items and
response choices were discussed with a bilingual health care
professional. The questionnaires were then completed by 10 healthy
Russian subjects. Difficulties with understanding the questions were
assessed and problems were identified. The questionnaires were
then translated backwards into English by an independent translator
and that translation was then compared with the original English
version. Finally, the steering group and all translators involved
agreed upon a final Russian version.
3. Results
3.1. Database Construction and Translation
into Russian
The web-based inception cohort database was created by imple-
menting clinical schemes as well as internationally validated
questionnaires. Schemes and questionnaires are available from the
menu in the database and sorted in the following categories for ease
of access: inclusion and yearly status, visit event, pediatric patients
and special events.
The security of the EpiComdatabase fulfills the requirements of the
participating countries' local data security agencies by being stored at a
single location. All questionnaires and schemes used in the databaseare available for download in pdf-format to be used in case record
forms by the participants. The database is available online at www.
epicom-ecco.eu and between January 1st and December 31st 2010
1336 patientswere included. The incidenceof theparticipating centers
can be viewed online on the inclusion chart on the project website.
3.2. Database Validation
Participants from 39 centers representing 24 countries were invited
to take part in the validation process. 36 (92%) centers from 13
Western European countries (26 centers) and 10 Eastern European
countries (10 centers) took part in the first round of validation. In
the second round 23 (59%) centers from 11 Western European
countries (18 centers) and 5 Eastern European countries (5 centers)
participated. Half of the participants stated that they had never
been involved in inception cohort studies before.
At the first validation, the participants found a number of errors in
the questionnaires (e.g. it was impossible to correct wrong entries in
some questionnaires and the internal validation of the diagnostic
criteria did notwork in some scenarios), and in the presented proposals
for changes in the design and setup of the database (e.g. additional
options in somequestionnairesmaking itmore suitable for daily use and
deletion of unimportant parameters). All comments were taken into
consideration and implemented in thedatabase.No further errorswere
reported or comments given on the database at the second validation.
After the second validation 81% of the participants found the
database overall to be “good” or “very good” compared to 68% after
the first round, Fig. 3. The general applicability of the database for the
projectwas evaluated as “good”or“very good”by77%after the second
round compared to 70% after the first, Fig. 4. However the changes
between the validation rounds were not significant (p=0.27 and
p=0.58 respectively). The participants did not find the database less or
more time-consuming after the second validation round. However, the
database being time-consuming was certainly an issue for the
participants as a majority found the database time-consuming and
approximately 30% found it too time-consuming, as depicted in Fig. 5.
3.3. Database Translation into Russian
The 10 healthy Russian subjects reported no obvious problems with
understanding the Russian translation of the questionnaires. The
1. validation
2. validation
Is the database overall too ’time consuming’
0%
Unacceptable Yes, very much Yes Moderately No
11%
14%
25%
50%
55%
14%
18%
14%
Figure 5 Time consumption, 1st validation vs. 2nd validation.
9%
17%
23%
51%
5%
14%
36%
45%
Very good Good Satisfying Unsatisfying/Unacceptable
1. Validation 2. Validation
Figure 3 Overall satisfaction, 1st validation vs. 2nd validation.
348 J. Burisch et al.backward translations were very similar to the original question-
naires, differing only in the syntax. The EpiCom database was thus
translated successfully and the desired language can easily be
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 4. Discussion
We have constructed a user-friendly, tailor-made and secure web-
based inception cohort database, facilitating remote data input
from around the world. The database is protected against invalid
data entry by built-in controls and validation tests and the incidence
of IBD in all 23 participating countries can be seen online on the
project website, www.epicom-ecco.eu.
The database has been tested, validated and changed in
accordance with comments and errors found by the participants of
the EpiCom-project, thus involving the participants from the beginning
and introducing them gradually to the concept. No significant positive
change in the general satisfaction and applicability after the
implementation of changes was found at the second validation
round. However, these variables were very positive after the first
validation, thus leaving little room for improvement. Also, a number of
participant centers dropped out of the validationprocess after the first
round, thereby making a comparison difficult. Nonetheless, there was
a general trend of increased satisfaction with the database.
Between January 1st and December 31st 2010, 1336 patients
were included in the database. Despite web-based registration it is
still very time-consuming to carry out inception cohort studies, as
the varying inclusion rates of the participating centers show (Fig. 1).
In some cases, participants lack the time to continually enter the
included patients in the database, thus partly explaining the low
numbers of included patients at some centers. After establishing the
EpiCom Nurse project regarding health quality of care, we have
observed that in centers where nurses are involved in EpiCom,9%
23%
21%
47%
5%
18%
36%
41%
1. Validation 2. Validation
Very good Good Satisfying Unsatisfying/Unacceptable
Figure 4 General applicability, 1st validation vs. 2nd validation.patient inclusion is improved (data not shown). Thus, the combined
efforts of doctors and nurses are recommended.
In future the database will be translated into the respective
languages of participating countries following the methods described
above or by using already translated and validated questionnaires
available in those languages. A Spanish version of EpiCom is in progress.
This will facilitate data entry and make the database a useful tool for
future studies. Furthermore, a patient-oriented addition to the
database is in progress, offering an overview of medication and
disease activity for the patients. Web-based questionnaires not only
offer a range of benefits for the investigator17 but may also enhance
the patient's compliance.
In conclusion, this concept of a secure web-based database has
great potential for performing inception cohort studies and may
serve as a template for future multi-national follow-up studies.
Furthermore, the database can be used as a clinical assessment for
imminent biobanking in ECCO and Europe. Upcoming papers will
address the East–West-gradient in the incidence of IBD in the
participating countries and as well as the patient data from 1 to
2 years follow-up after diagnosis (medical treatment, surgery,
cancer, biological treatment etc.). Future EpiCom trials will address
the long-term outcome in the included IBD patients.Acknowledgements
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